13-20462782-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015974.3(CRYL1):c.277-23028T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.609 in 151,292 control chromosomes in the GnomAD database, including 32,177 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.61 ( 32177 hom., cov: 27)
Consequence
CRYL1
NM_015974.3 intron
NM_015974.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.25
Publications
4 publications found
Genes affected
CRYL1 (HGNC:18246): (crystallin lambda 1) The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate. A similar gene in the rabbit is thought to serve a structural role in the lens of the eye. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRYL1 | NM_015974.3 | c.277-23028T>C | intron_variant | Intron 3 of 7 | ENST00000298248.12 | NP_057058.2 | ||
CRYL1 | NM_001363647.2 | c.276+26588T>C | intron_variant | Intron 3 of 6 | NP_001350576.1 | |||
CRYL1 | XM_005266416.6 | c.277-23028T>C | intron_variant | Intron 3 of 5 | XP_005266473.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.610 AC: 92200AN: 151174Hom.: 32179 Cov.: 27 show subpopulations
GnomAD3 genomes
AF:
AC:
92200
AN:
151174
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.609 AC: 92210AN: 151292Hom.: 32177 Cov.: 27 AF XY: 0.612 AC XY: 45189AN XY: 73862 show subpopulations
GnomAD4 genome
AF:
AC:
92210
AN:
151292
Hom.:
Cov.:
27
AF XY:
AC XY:
45189
AN XY:
73862
show subpopulations
African (AFR)
AF:
AC:
10148
AN:
41138
American (AMR)
AF:
AC:
9703
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
AC:
2853
AN:
3468
East Asian (EAS)
AF:
AC:
3688
AN:
5120
South Asian (SAS)
AF:
AC:
3909
AN:
4768
European-Finnish (FIN)
AF:
AC:
7331
AN:
10448
Middle Eastern (MID)
AF:
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52423
AN:
67844
Other (OTH)
AF:
AC:
1351
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1380
2760
4140
5520
6900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2440
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.